共 81 条
[1]
Kalil AC(2016)Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society Clin Infect Dis 63 e61-e111
[2]
Metersky ML(2010)Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia Clin Infect Dis 51 S81-S87
[3]
Klompas M(2017)Antimicrobial activity of ceftazidime-avibactam against gram-negative bacteria isolated from patients hospitalized with pneumonia in US medical centers, 2011 to 2015 Antimicrob Agents Chemother 61 e02083-16-1301
[4]
Jones RN(2016)Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014 Infect Control Hosp Epidemiol 37 1288-02018
[5]
Sader HS(2018)Treating nosocomial pneumonia: what’s new ERJ Open Res 4 00058-S17
[6]
Castanheira M(2010)Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design Clin Infect Dis 51 S12-352
[7]
Flamm RK(2019)A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia Crit Care Med 47 345-256
[8]
Weiner LM(2012)Economic impact of ventilator-associated pneumonia in a large matched cohort Infect Control Hosp Epidemiol 33 250-1197
[9]
Webb AK(2015) nosocomial pneumonia: impact of pneumonia classification Infect Control Hosp Epidemiol 36 1190-S125
[10]
Limbago B(2010)Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia Clin Infect Dis 51 S120-S428